Document Detail


Lack of effect of aspirin on myocardial infarct size in the dog.
MedLine Citation:
PMID:  7468475     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pretreatment with platelet-inhibitory doses of aspirin (3 mg/kg body weight) has been shown to augment epicardial collateral flow by more than 50 percent (p less than 0.05) 4 hours after ligation of the left anterior descending coronary artery in dogs. To determine whether this favorable influence of aspirin is sufficient to decrease the amount of infarcted tissue, either intravenous aspirin, 3 mg/kg (n = 17), or saline solution (n = 17) was administered to dogs 10 minutes before occlusion of the left anterior descending coronary artery. Administration of saline solution or aspirin was repeated every 24 hours. By 72 hours, 5 dogs in each treatment group had died. Survivors were killed at 72 hours. The portion of the left ventricle at risk of infarction was delineated by perfusion of the aortic root with Evans blue and simultaneous perfusion of the distal left anterior descending coronary artery with saline solution under equal physiologic pressures. Slices of the stained heart were incubated with triphenyltetrazolium to identify gross infarct (with histologic confirmation). Total mass of left ventricle, myocardium at risk, and infarct size were measured in each dog. A direct relation was found between the mass at risk and the mass infarcted (r = 0.84, p less than 0.001). Aspirin-treated dogs did not differ from control dogs in percent ventricle at risk (mean +/- standard error 37 +/- 2 versus 40 +/- 2), percent infarct weight/left ventricle (29 +/- 3 versus 31 +/- 2) or percent infarct weight/weight of ventricle at risk (78 +/- 4 versus 77 +/- 3). Thus, despite aspirin's ability to inhibit platelet aggregation and to increase epicardial collateral flow by more than 50 percent, aspirin treatment failed to reduce infarct size in this dog model.
Authors:
R O Bonow; L C Lipson; F H Sheehan; N L Capurro; J M Isner; W C Roberts; R E Goldstein; S E Epstein
Related Documents :
2210895 - Pharmacologic modifications of reperfusion arrhythmias in the dog in vivo: possible rel...
21700305 - Implanted bone marrow-derived mesenchymal stem cells fail to metabolically stabilize or...
16178395 - Effects of animal position and number of repeated measurements on selected two-dimensio...
6890805 - Lack of thromboxane a2 involvement in the arrhythmias occurring during acute myocardial...
11220475 - Seat belt aorta: endovascular management with a stent-graft.
1451125 - Risk stratification after acute myocardial infarction by means of echocardiographic wal...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  47     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1981 Feb 
Date Detail:
Created Date:  1981-04-21     Completed Date:  1981-04-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  258-64     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Aspirin / therapeutic use*
Blood Platelets / drug effects
Coronary Disease / physiopathology
Coronary Vessels / physiopathology
Dogs
Dose-Response Relationship, Drug
Female
Hemodynamics / drug effects
Male
Myocardial Infarction / drug therapy*
Risk
Chemical
Reg. No./Substance:
50-78-2/Aspirin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human ventricular refractoriness: effects of increasing current.
Next Document:  Regional myocardial kinetics of lidocaine in experimental infarction: modulation by regional blood f...